Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Mar 24;31(6):1260–1267. doi: 10.1161/ATVBAHA.110.220202

Figure 1.

Figure 1

(A) Expression of foam cell marker genes in macrophages treated with TCDD or CSE in absence or presence of MNF. Significantly different from control (*) or from CSE and TCDD alone (**). (B–C) Expression of (B) VEGF and (C) CYP1A1 in macrophages treated with TCDD for 24h after transient transfection with siRNA against AhR or IL-8 for 48h. Significantly different from control (*) or from TCDD treated siControl (**). (D) Cholesterol accumulation in macrophages treated with TCDD or CSE in the absence or presence of MNF, INCB3344 or SB225002. Significantly different from control (*) or from corresponding CSE or TCDD-treated cells (**). *P< 0.05.